Cocrystal Pharma, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cocrystal Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Cocrystal Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $252K, a 54.8% decline year-over-year.
  • Cocrystal Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $331K, a 37.5% decline year-over-year.
  • Cocrystal Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $801K, a 6.32% decline from 2022.
  • Cocrystal Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $855K, a 18.1% increase from 2021.
  • Cocrystal Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $724K, a 9.37% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $801K -$54K -6.32% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $855K +$131K +18.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $724K +$62K +9.37% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $662K +$311K +88.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $351K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.